CHL1 depletion affects dopamine receptor D2-dependent modulation of mouse behavior.
CHL1
behavior
close homolog of L1
dopamine
dopamine receptor D2
quinpirole
sulpiride
Journal
Frontiers in behavioral neuroscience
ISSN: 1662-5153
Titre abrégé: Front Behav Neurosci
Pays: Switzerland
ID NLM: 101477952
Informations de publication
Date de publication:
2023
2023
Historique:
received:
04
09
2023
accepted:
26
10
2023
medline:
29
11
2023
pubmed:
29
11
2023
entrez:
29
11
2023
Statut:
epublish
Résumé
The dopaminergic system plays a key role in the appropriate functioning of the central nervous system, where it is essential for emotional balance, arousal, reward, and motor control. The cell adhesion molecule close homolog of L1 (CHL1) contributes to dopaminergic system development, and CHL1 and the dopamine receptor D2 (D2R) are associated with mental disorders like schizophrenia, addiction, autism spectrum disorder and depression. Here, we investigated how the interplay between CHL1 and D2R affects the behavior of young adult male and female wild-type (CHL+/+) and CHL1-deficient (CHL1-/-) mice, when D2R agonist quinpirole and antagonist sulpiride are applied. Low doses of quinpirole (0.02 mg/kg body weight) induced hypolocomotion of CHL1+/+ and CHL1-/- males and females, but led to a delayed response in CHL1-/- mice. Sulpiride (1 mg/kg body weight) affected locomotion of CHL1-/- females and social interaction of CHL1+/+ females as well as social interactions of CHL1-/- and CHL1+/+ males. Quinpirole increased novelty-seeking behavior of CHL1-/- males compared to CHL1+/+ males. Vehicle-treated CHL1-/- males and females showed enhanced working memory and reduced stress-related behavior. We propose that CHL1 regulates D2R-dependent functions
Identifiants
pubmed: 38025382
doi: 10.3389/fnbeh.2023.1288509
pmc: PMC10665519
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1288509Informations de copyright
Copyright © 2023 Fernandes, Kleene, Congiu, Freitag, Kneussel, Loers and Schachner.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Références
Nature. 1979 Jan 11;277(5692):93-6
pubmed: 215920
J Neuroimmune Pharmacol. 2017 Dec;12(4):602-623
pubmed: 28578466
J Pharmacol Exp Ther. 1992 Jul;262(1):303-11
pubmed: 1352551
Proc Natl Acad Sci U S A. 2020 Mar 31;117(13):7418-7429
pubmed: 32170006
J Neurosci. 2012 Jun 27;32(26):9023-34
pubmed: 22745501
Learn Mem. 2005 Jul-Aug;12(4):399-406
pubmed: 16077018
Nature. 2000 Nov 9;408(6809):199-203
pubmed: 11089973
Trends Pharmacol Sci. 2008 Oct;29(10):493-8
pubmed: 18755516
Acta Neurobiol Exp (Wars). 2007;67(4):481-8
pubmed: 18320725
Mol Psychiatry. 2002;7(4):412-5
pubmed: 11986985
Am J Hum Genet. 2003 Jul;73(1):34-48
pubmed: 12802786
J Neurobiol. 2003 Oct;57(1):67-80
pubmed: 12973829
Front Pediatr. 2021 Feb 10;9:618059
pubmed: 33643973
EMBO J. 1989 Dec 20;8(13):4025-34
pubmed: 2531656
Front Psychiatry. 2022 Feb 03;12:787097
pubmed: 35185637
Psychopharmacology (Berl). 1998 Jan;135(2):182-93
pubmed: 9497024
J Comp Neurol. 2009 Apr 10;513(5):496-510
pubmed: 19226508
Biochem Soc Trans. 2010 Apr;38(2):445-51
pubmed: 20298200
Neurosci Biobehav Rev. 2002 Jan;26(1):91-104
pubmed: 11835987
Neuron. 2006 Dec 21;52(6):1011-25
pubmed: 17178404
J Neurosci. 2019 Aug 7;39(32):6233-6250
pubmed: 31182634
Front Psychol. 2013 Dec 11;4:907
pubmed: 24376428
Brain Res. 1983 Oct;287(2):173-96
pubmed: 6357357
J Gene Med. 2010 Jul;12(7):561-3
pubmed: 20607692
Eur J Neurosci. 1999 Mar;11(3):813-26
pubmed: 10103075
Psychol Bull. 1976 May;83(3):482-504
pubmed: 17582919
J Neurosci. 2008 Dec 10;28(50):13505-10
pubmed: 19074023
Neuroscience. 2014 Dec 12;282:13-22
pubmed: 24463000
Int J Neuropsychopharmacol. 2013 Apr;16(3):661-76
pubmed: 22647577
Biomolecules. 2022 Jun 24;12(7):
pubmed: 35883437
Behav Brain Res. 2003 Oct 17;145(1-2):189-207
pubmed: 14529817
Neurobiol Learn Mem. 2011 Sep;96(2):254-62
pubmed: 21619938
Front Behav Neurosci. 2023 Feb 16;17:1060786
pubmed: 36873775
Neural Plast. 2003;10(1-2):107-20
pubmed: 14640312
Eur J Pharmacol. 1989 Feb 28;161(2-3):151-7
pubmed: 2566488
Med Res Rev. 2023 Jan;43(1):55-211
pubmed: 36111795
Pharmacol Biochem Behav. 2002 Jul;72(4):857-63
pubmed: 12062575
Eur J Neurosci. 2006 Apr;23(7):1839-52
pubmed: 16623841
Front Pharmacol. 2020 Mar 31;11:394
pubmed: 32296337
Front Cell Neurosci. 2021 Jan 13;14:611379
pubmed: 33519384
Neuropsychopharmacology. 2021 Feb;46(3):491-499
pubmed: 33318634
J Pharmacol Exp Ther. 1999 Feb;288(2):774-81
pubmed: 9918588
Personal Neurosci. 2020 Jun 23;3:e7
pubmed: 32656492
Brain Sci. 2021 Sep 11;11(9):
pubmed: 34573220
Methods Mol Biol. 2019;1916:105-111
pubmed: 30535688
PLoS One. 2011;6(10):e26049
pubmed: 22016809
Int J Mol Sci. 2022 Apr 19;23(9):
pubmed: 35562898
J Neurochem. 2001 Apr;77(2):493-504
pubmed: 11299312
Pharmacol Rev. 2011 Mar;63(1):182-217
pubmed: 21303898
J Neurosci. 2000 Nov 15;20(22):8305-14
pubmed: 11069937
Br J Pharmacol. 1997 Jun;121(4):731-6
pubmed: 9208141
FASEB J. 2020 Apr;34(4):4832-4851
pubmed: 32052901
Rev Neurosci. 2019 Apr 24;30(3):325-337
pubmed: 30179855
Front Neurosci. 2022 Sep 16;16:947295
pubmed: 36188456
Brain Res. 1991 Jun 14;551(1-2):216-20
pubmed: 1680523
J Pharmacol Sci. 2017 Oct 14;:
pubmed: 29107444
Psychopharmacology (Berl). 2010 Mar;208(4):585-92
pubmed: 20066401
Sci Rep. 2017 Aug 24;7(1):9368
pubmed: 28839197
Neuron Glia Biol. 2008 Aug;4(3):197-209
pubmed: 19674506
Behav Pharmacol. 2022 Oct 1;33(7):435-441
pubmed: 36148834
Trends Neurosci. 2007 May;30(5):188-93
pubmed: 17368565
J Biol Chem. 2003 Jul 4;278(27):25024-31
pubmed: 12721290
Nat Rev Dis Primers. 2020 Jan 16;6(1):5
pubmed: 31949163
Psychopharmacology (Berl). 1995 Jun;119(3):299-304
pubmed: 7675965
Psychopharmacology (Berl). 2001 Apr;154(4):350-5
pubmed: 11349387
Clin Exp Pharmacol Physiol. 1997 Sep-Oct;24(9-10):764-9
pubmed: 9315386
Front Neural Circuits. 2021 Jul 23;15:700968
pubmed: 34366796
Pharmacol Biochem Behav. 1995 Mar;50(3):389-97
pubmed: 7617677
Neuropharmacology. 1993 Jan;32(1):93-100
pubmed: 8094236
Schizophr Res. 2005 Mar 1;73(2-3):269-74
pubmed: 15653271
Neuropsychopharmacology. 2006 Jun;31(6):1193-202
pubmed: 16237396
Anim Behav. 1973 May;21(2):205-35
pubmed: 4578750
Front Pharmacol. 2022 Aug 30;13:953652
pubmed: 36133803
Stress. 2018 Sep;21(5):443-452
pubmed: 29451062
J Vis Exp. 2015 Feb 06;(96):e52434
pubmed: 25742564
J Recept Signal Transduct Res. 2004 Aug;24(3):165-205
pubmed: 15521361
Exp Brain Res. 2000 Jul;133(1):130-8
pubmed: 10933217
Psychopharmacology (Berl). 2012 May;221(1):101-13
pubmed: 22160162
Physiol Behav. 2009 Jun 22;97(3-4):394-400
pubmed: 19303029
Nat Rev Neurosci. 2023 Mar;24(3):134-152
pubmed: 36653531
Neurosci Biobehav Rev. 2010 Apr;34(5):660-9
pubmed: 19715723
J Parkinsons Dis. 2015;5(3):625-36
pubmed: 25870025
Pharmacol Res. 2019 Jan;139:440-445
pubmed: 30528973
Behav Brain Res. 2003 Dec 17;147(1-2):31-9
pubmed: 14659567
J Neural Transm (Vienna). 2017 May;124(5):525-542
pubmed: 28283756
Brain Res Bull. 1991 Nov;27(5):743-6
pubmed: 1684529
J Neurochem. 2015 Nov;135(4):830-44
pubmed: 26285062
Cell Commun Signal. 2013 May 17;11(1):34
pubmed: 23683503
Brain Res. 2004 Dec 10;1029(1):131-4
pubmed: 15533325
Biomedicines. 2023 Mar 14;11(3):
pubmed: 36979877
Neuron. 2004 Oct 28;44(3):423-37
pubmed: 15504324
Neural Netw. 2002 Jun-Jul;15(4-6):549-59
pubmed: 12371511
Cell Mol Neurobiol. 2019 Jan;39(1):31-59
pubmed: 30446950
Mol Cell Biol. 2002 Nov;22(22):7967-81
pubmed: 12391163
Curr Pharm Des. 2006;12(20):2487-500
pubmed: 16842172
Pharmacol Toxicol. 1997 Sep;81(3):105-13
pubmed: 9335067
Int Rev Neurobiol. 2007;78:41-68
pubmed: 17349857
Behav Brain Res. 2016 Jul 15;308:211-6
pubmed: 27059337
Biochem Biophys Res Commun. 1991 Sep 16;179(2):824-9
pubmed: 1832861
Neuropediatrics. 2013 Oct;44(5):268-71
pubmed: 23436495
Pharmacol Biochem Behav. 1999 Jan;62(1):21-9
pubmed: 9972841
Trends Neurosci. 2007 May;30(5):194-202
pubmed: 17408759
Eur J Pharmacol. 1993 Jun 4;236(3):385-93
pubmed: 8102970
Proc Natl Acad Sci U S A. 2018 Jan 2;115(1):198-203
pubmed: 29255027
Int J Mol Sci. 2015 Dec 17;16(12):30144-63
pubmed: 26694375
Chem Commun (Camb). 2015 May 21;51(41):8618-21
pubmed: 25896577
Behav Brain Res. 2015 Mar 15;281:283-9
pubmed: 25546724
Front Neurosci. 2021 Sep 29;15:705890
pubmed: 34658761
Hum Mol Genet. 2003 Jul 1;12(13):1463-74
pubmed: 12812975
PLoS One. 2010 Aug 11;5(8):e12018
pubmed: 20711454
Eur J Pharmacol. 2003 Feb 28;463(1-3):3-33
pubmed: 12600700
J Neurosci Res. 2005 Jun 1;80(5):593-9
pubmed: 15880726
Sci Rep. 2017 Feb 24;7:43348
pubmed: 28233850
Mol Cell Neurosci. 2007 Feb;34(2):121-36
pubmed: 17126027
Neuron. 2022 Nov 16;110(22):3789-3804.e9
pubmed: 36130595
Int J Mol Sci. 2023 Apr 04;24(7):
pubmed: 37047716
Int J Neuropsychopharmacol. 2017 Dec 1;20(12):1036-1046
pubmed: 29106542
Elife. 2017 Jan 05;6:
pubmed: 28054919
Physiol Behav. 1997 Dec 31;63(1):137-41
pubmed: 9402626
J Neuroimmune Pharmacol. 2020 Mar;15(1):114-164
pubmed: 31077015
Brain Res. 2004 Nov 26;1028(1):75-82
pubmed: 15518644
Nat Neurosci. 2022 Jul;25(7):900-911
pubmed: 35710984
Adv Pharmacol. 2014;70:175-214
pubmed: 24931197
J Auton Nerv Syst. 1998 Oct 15;72(2-3):187-94
pubmed: 9851568
Pharmacol Biochem Behav. 1994 Jul;48(3):781-6
pubmed: 7938135
Brain Res Brain Res Protoc. 2004 Aug;13(3):151-8
pubmed: 15296852